Highlights: Avecho and Sandoz sign an exclusive ten-year development and license agreement (“Agreement”) for Avecho’s pharmaceutical cannabidiol capsule for insomnia in Australia Avecho to receive upfront, milestone and royalty payments: US$3M (~A$4.8M[1]) in upfront payment US$16M in…